MRVI Chart
- 52-Week Range: $24.46 - $60.62
- Market Capitalization: $9.11B
- Short Percentage: 0%
- Target Price: $44.38
- Shares Outstanding: 131.54M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
MRVI released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Maravai LifeSciences Announces May and June 2022 Investor Conference ScheduleGlobeNewsWire | May 11th
- Maravai LifeSciences To Host Earnings Conference Call on Thursday, May 5, 2022GlobeNewsWire | April 21st
- Maravai LifeSciences Holdings, Inc. (MRVI) Carl Hull on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha | February 23rd
- Maravai LifeSciences Acquires MyChem, a Leader in Proprietary Ultra-Pure NucleotidesGlobeNewsWire | January 28th
- Maravai LifeSciences Announces Establishment of New Charitable FoundationGlobeNewsWire | December 9th
- Maravai LifeSciences Holdings, Inc. (MRVI) CEO Carl Hull on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha | November 10th
Company Info
Website: https://www.maravai.com
Address: 10770 Wateridge Circle, San Diego, CA, United States, 92121
Sector: Healthcare
Industry: Biotechnology
Full time employees: 470
Address: 10770 Wateridge Circle, San Diego, CA, United States, 92121
Sector: Healthcare
Industry: Biotechnology
Full time employees: 470
$MRVI bear trap
$MRVI go green today and we gap up tomrrow
$MRVI gap it slap it ask it !
$MRVI oh my!
$MRVI the best advice has been no stop losses. Would have cost a fortune!!!